Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - CannLabs, Inc.ex99-1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

_________________________

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (date of earliest event reported): November 14, 2014

 

CANNLABS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Nevada 333-155318 20-5337455
(State or other Jurisdiction
of Incorporation or
Organization)
(Commission File
Number)
(I.R.S. Employer
Identification No.)

  

3888 E. Mexico Ave., Suite 202

Denver, CO 80210

(Address of principal executive offices) (Zip Code)

 

(303) 309-0105

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

 

Item 2.02.      Results of Operations and Financial Condition.

On November 14 2014, CannLabs, Inc. (the “Company”) issued a press release announcing its financial results for its third quarter of 2014. A copy of the press release issued by the Company on November 11, 2014 is attached as Exhibit 99.1.

The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.

 

Item 9.01.      Financial Statements and Exhibits.

(d) Exhibits
   
99.1 Press release of CannLabs, Inc., dated as of November 14, 2014

 

 
 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  CANNLABS, INC.  
     
     
     
Dated: November 14, 2014 /s/ Scott McPherson  
  Scott McPherson  
  Chief Financial Officer